Lack of Funding Limits County Officials' Ability to Fight Substance Abuse Crisis

Hydrocodone is said to be one of the most common recreational prescription drugs in America.

Hydrocodone is said to be one of the most common recreational prescription drugs in America. David Smart / Shutterstock.com

 

Connecting state and local government leaders

They're willing to collaborate and try innovative solutions, but until treatment and prevention programs are fully funded, it will continue to be an uphill battle.

WASHINGTON — Drug overdoses are now the leading cause of accidental death in the United States and heroin overdoses account for more than half of those deaths.

“Counties are the boots on the ground” in the fight against the substance abuse epidemic.

That’s according to National Association of Counties President Sallie Clark, who kicked off the first of two workshop sessions dedicated to substance abuse at NACo's 2016 Legislative Conference in the nation’s capital, which continues this week.

Given the number of jails, 911 call centers, mental health facilities and public health facilities that are financed and operated on the county level, Clark, a commissioner in El Paso County, Colorado, views county governments as the “front lines of the crisis” and acknowledges that it will take “an all-hands-on-deck approach to improve the health and safety for those at risk.”

In keeping with this call for collaboration, NACo announced on Monday that it is joining with the National League of Cities in an effort to fight substance abuse in local communities. The two organizations will create a joint national task force made up of city and county leaders from across the country. “This new initiative will build on our efforts to mitigate this crisis and strengthen the safety and security of our neighborhoods,” Clark said in an announcement.

The need for greater collaboration was a theme that ran throughout both conference sessions on substance abuse. “More than ever we have to be in this together,” said Mary Lou Leary, deputy director of state, local and tribal affairs for the Office of National Drug Control Policy, calling for cooperation across various levels of government.

Beyond multi-level government collaboration, many county officials speaking on the issue emphasized the need for bringing multiple sectors and disciplines into the broader conversation. The era of assuming that responsibility for drug issues falls solely on the shoulders of police departments and prison systems seems to be over.

County officials expressed widespread consensus throughout these discussions that this epidemic needs to be thought of as an issue for public health systems, mental health systems, the education sector, the private sector and others.

“This epidemic can’t be addressed by the justice system or the health system alone but requires a collective and coordinated effort,” said Joan Garner, a commissioner in Fulton County, Georgia, which includes Atlanta.

Medical professionals—particularly those who prescribe painkillers—are one group that must be included in the dialogue on substance abuse prevention measures.

According to current data, painkillers are so heavily prescribed that, if the total number of prescriptions were to be added up, there would be enough to give one to every adult in the United States, a fact cited by Michael Botticelli, the director of national drug control policy, during Monday morning's conference session.

“Doctors get training on pain management in medical school and are taught to prescribe opioids. But they need more education about the appropriate amount to prescribe,” Leary noted, adding that “oftentimes, the medical community underestimates the addictive potential of prescription painkillers.”

In the same vein, Dr. LaMar Hasbrouck, a physician and director of the National Association of County and City Health Officials, argued that simply educating physicians doesn’t go far enough. The patient, as the consumer, must be made aware of the risks of taking this type of medication.

Going beyond the "why" of collaboration and getting into the "how," panelist Thomas Carr, executive director of the Washington Baltimore High Intensity Drug Trafficking Area, encouraged the county officials in attendance to make the exchange of data and information across sectors a priority.

“All of us have to work together to tear down the silos,” Carr said, directing his remarks to the practitioners in the room. “Law enforcement, you have to share information with public health. Public health, you have to share information with law enforcement . . . get the information going back and forth.”

Mike Nerheim, the states attorney in Lake County, Illinois, presented his county, which is located north of Chicago, as an example of another way to prioritize collaboration. He helped form the Lake County Opioid Initiative, which now has 300 members that represent a diverse range of backgrounds–from behavioral health professionals to police officers.

One of the first projects LCOI undertook was to train and equip police officers with Naloxone, a drug that can reverse the deadly effects of an overdose. Since this program took effect at the end of 2014, police officers have used Naloxone to save 56 lives, according to the county.

However Nerheim, along with many other county officials in attendance, acknowledged that Naloxone-based initiatives alone are not enough to fully tackle this crisis. Nerheim emphasized that “the police can save a life, but if that person isn’t put into treatment immediately, that is only a temporary solution.”

County officials agreed that, while evidence-based treatment and prevention are the most important part of tackling the crisis, they are also the weakest links in the current response.

Treatment is more complicated than giving someone a dose of Naloxone and sending them on their way. In his panel presentation, Carr cautioned county officials that treatment “has to be immediate,” and added that treatment takes time. “If you’re trying out two-month programs, forget it. You need a minimum of six months for treatment.”

Unfortunately, many counties don’t have the infrastructure needed for evidence-based treatment, let alone the funds necessary to manage these extensive programs. One audience member in the second part of Monday’s discussion, Wendell Bostick, a commissioner in Curry County, New Mexico, explained to the panel that the wait time for a bed in a treatment facility in New Mexico starts at six weeks, well beyond the “immediate” response Carr recommends.

Matthew Bell, commissioner for Weber County, Utah, said he faced a similar problem. “We all know treatment is the best option,” he acknowledged. But, when discussing the treatment options in Weber County, Bell added, “we just don’t have enough bed space.”

The question of how to finance these treatment options at a scale that matches the current epidemic remains unanswered. The Obama Administration has made this issue a priority by proposing that $1.1 billion of the budget be allocated to treatment and prevention of opioid addiction. Until funding for these programs is found, counties will continue to operate with treatment budgets that simply do not match the level of need.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.